# Atea Pharmaceuticals, Inc.: Form 8-K, filed Feb 24, 2025

- Company: [Atea Pharmaceuticals, Inc.](/companies/avir.md) (CIK 1593899)
- Form: 8-K
- Filed: 2025-02-24
- Accepted by EDGAR: Feb 24, 2025, 08:17 ET
- Period: 2025-02-20
- Accession: 0001193125-25-032826
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1593899/000119312525032826/d918567d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1593899/000119312525032826/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1593899/000119312525032826/d918567d8k.htm

Filed Feb 24, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-032826. Last ingested by Listed: Nov 10, 2026, 04:06 ET. No prices; not investment advice.